News headlines about Humana (NYSE:HUM) have trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Humana earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned headlines about the insurance provider an impact score of 46.100154503389 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the news headlines that may have impacted Accern’s analysis:
- Walmart talking with Humana on closer ties; acquisition possible: sources (feeds.reuters.com)
- UPDATE 3-Walmart talking with Humana on closer ties; acquisition possible -sources (feeds.reuters.com)
- UPDATE 2-Walmart talking with Humana on closer ties; purchase possible -sources (feeds.reuters.com)
- Humana shares surge after report of Walmart acquisition talks (feeds.marketwatch.com)
- Walmart reportedly in early talks to buy Humana (cnbc.com)
NYSE HUM opened at $268.83 on Friday. The company has a market cap of $36,837.44, a P/E ratio of 16.12, a PEG ratio of 1.45 and a beta of 0.95. Humana has a twelve month low of $204.98 and a twelve month high of $293.35. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.85 and a current ratio of 1.85.
The company also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, March 30th will be paid a dividend of $0.50 per share. The ex-dividend date is Wednesday, March 28th. This is a positive change from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 0.74%. Humana’s dividend payout ratio is presently 11.99%.
Humana declared that its Board of Directors has approved a share repurchase plan on Thursday, December 14th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the insurance provider to repurchase shares of its stock through open market purchases. Shares buyback plans are typically an indication that the company’s management believes its shares are undervalued.
A number of equities analysts have commented on HUM shares. Leerink Swann lifted their price objective on shares of Humana from $280.00 to $300.00 and gave the stock an “outperform” rating in a research report on Thursday, February 8th. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $297.00 target price for the company in a research note on Monday, January 15th. ValuEngine cut Humana from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Cantor Fitzgerald reiterated a “hold” rating and issued a $250.00 target price on shares of Humana in a report on Wednesday, February 7th. Finally, Oppenheimer upped their target price on Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a report on Thursday, February 8th. Eight analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Humana has an average rating of “Buy” and an average target price of $270.47.
In related news, CEO Bruce D. Broussard sold 14,075 shares of the stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $274.32, for a total value of $3,861,054.00. Following the transaction, the chief executive officer now owns 113,896 shares of the company’s stock, valued at $31,243,950.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider M Todoroff Christopher sold 16,389 shares of the stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $273.37, for a total value of $4,480,260.93. Following the completion of the transaction, the insider now directly owns 13,447 shares in the company, valued at approximately $3,676,006.39. The disclosure for this sale can be found here. Over the last three months, insiders have sold 31,660 shares of company stock valued at $8,668,218. 0.60% of the stock is owned by corporate insiders.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.